Evogene Ltd. (EVGN)
Price:
1.34 USD
( - -0.12 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Vertex Pharmaceuticals Incorporated
VALUE SCORE:
8
2nd position
Harmony Biosciences Holdings, Inc.
VALUE SCORE:
12
The best
Agios Pharmaceuticals, Inc.
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
NEWS
EverGen Infrastructure Provides Operations and Development Updates
businesswire.com
2025-09-26 19:13:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) today provided an update on operations across its renewable natural gas (“RNG”) and organic waste processing facilities. During July and August 2025, EverGen's Fraser Valley Biogas (“FVB”) and GrowTEC facilities produced approximately 16,000 gigajoules ("GJs") (~520 GJ/d) in July and more than 17,000 GJs (~550 GJ/d) in August. These results highlight continued momentum at EverGen.
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
prnewswire.com
2025-08-28 07:00:00REHOVOT, Israel , Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer Haviv, Evogene's President and CEO, will present at the H.C.
EverGen Infrastructure Reports Q2 2025 Results
businesswire.com
2025-08-21 21:42:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), today reported financial results as at and for Q2 2025. All amounts are in Canadian dollars unless otherwise stated and have been prepared in accordance with IFRS. Strategic & Financing Updates $5 Million Private Placement: In May 2025, EverGen completed a $5 million non-brokered private placement of common shares with Ask America, LLC strengthening the Compan.
EverGen Infrastructure Announces Dates for 2025 Second Quarter Financial Results and Conference Call
businesswire.com
2025-08-19 18:28:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today announced plans to release its 2025 second quarter financial results on August 21, 2025, after market close. EverGen will hold a results and corporate update conference call at 11:00 a.m. eastern time on Friday, August 22, 2025, hosted by Chief Executive Officer, Chase Edgelow. Conference Call Details are as follows: Date: Friday, August 22, 2025 Time: 11:00.
Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-19 13:31:58Evogene Ltd. (NASDAQ:EVGN ) Q2 2025 Earnings Conference Call August 19, 2025 9:00 AM ET Company Participants Ofer Haviv - CEO, President & Director Yaron Eldad - Chief Financial Officer Unidentified Company Representative Welcome to Evogene's Second Quarter 2025 Results Conference Call.
Evogene Reports Second Quarter 2025 Financial Results
prnewswire.com
2025-08-19 07:00:00Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: The financial results for the first half of 2025 of Lavie Bio, a subsidiary of Evogene and the MicroBoost AI for Ag operations, are presented as a single-line item in Evogene's consolidated statements of profit and loss for the first half of 2025. Their results are included under the line titled - "Loss from operations held for sale, net".
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
prnewswire.com
2025-08-12 07:00:00A failure in metabolite breakdown leads to their ordered self-assembly into pathological aggregates, such as in Tyrosinemia and Gout. REHOVOT, Israel , Aug. 12, 2025 /PRNewswire/ -- Evogene Ltd.
Evogene Schedules Second Quarter 2025 Financial Results Release
prnewswire.com
2025-07-29 07:00:00Zoom conference call scheduled for August 19, 2025, 9:00 AM ET REHOVOT, Israel , July 29, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Tuesday , August 19 , 2025.
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
prnewswire.com
2025-07-08 07:00:00REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to drive innovation in life-science product development, today announced the successful completion and closing of the previously disclosed transaction involving the divestiture of the majority of the activities and assets of its ag-biologicals subsidiary, Lavie Bio Ltd.
EverGen Infrastructure Corp. Announces Appointment of Maria O'Sullivan as Interim CFO
businesswire.com
2025-06-27 02:00:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) is pleased to announce the appointment of Maria O'Sullivan as its Interim Chief Financial Officer ("CFO"), effective immediately. Ms. O'Sullivan will replace Sean Hennessy who has resigned from his role as of the same day. "On behalf of the Board of Directors and the entire team at EverGen, I would like to thank Sean for his leadership and dedication. His contributions have been.
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
prnewswire.com
2025-06-10 07:00:00The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications REHOVOT, Israel , June 10, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing life-science product discovery and development, today announced the completion of its generative AI foundation model, version 1.0, for small molecule design, developed in collaboration with Google Cloud.
EverGen Infrastructure Corp. Announces Participation in the 2025 Canadian Climate Investor Conference
newsfilecorp.com
2025-06-09 18:19:00Vancouver, British Columbia--(Newsfile Corp. - June 9, 2025) - EverGen Infrastructure Corp. (TSXV: EVGN), a Canadian renewable energy company specializing in waste-to-energy projects, announced today that it will be presenting at the 2025 Canadian Climate Investor Conference (CCIC), taking place on Wednesday June 11, 2025 at the Arcadian Court in Toronto, Ontario. For a complete agenda of the conference and to register, see the conference website here: https://events.tsx.com/ccic/.
EverGen Infrastructure Reports Q1 2025 Results
businesswire.com
2025-05-30 20:14:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today reported financial results as at and for Q1 2025. All amounts are in Canadian dollars unless otherwise stated and have been prepared in accordance with IFRS. Financial Highlights for Q1 2025: Revenues of $1.9 million for Q1 2025 decreased 41% compared to the same period last year, primarily driven by reduced volumes (due to unexpected operating disturbances).
Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-05-21 14:08:24Evogene Ltd. (NASDAQ:EVGN ) Q1 2025 Earnings Conference Call May 21, 2025 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Operator Welcome to Evogene's First Quarter 2025 Results Conference Call.
Evogene Reports First Quarter 2025 Financial Results
prnewswire.com
2025-05-21 07:00:00Conference call and webcast: today, May 21, 2025, 9:00 am ET Financial Highlights: In the first quarter of 2025, total revenues were approximately $2.4 million, compared to approximately $4.2 million in the first quarter of 2024. The first quarter of 2024 revenues included license fee payments totaling $3.5 million - $2.5 million from Lavie Bio's license fee under its collaboration with Corteva, and $1.0 million from AgPlenus' license fee under its collaboration with Bayer.
EverGen Infrastructure Corp. Announces Receipt of TSX Venture Exchange Final Approval of Real Property Sale and Update to Previously Announced Financing
globenewswire.com
2025-05-14 20:37:00VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) is pleased to announced that, further to its press release dated March 17, 2025, the purchase and sale agreement dated March 13, 2025 with an effective date of February 28, 2025 (the “Agreement”) between 2065947 Alberta Ltd. and James Betts (collectively, the “Purchasers”) and Fraser Valley Biogas Ltd. (the “Vendor”), a subsidiary of the Company, has received final approval from the TSX Venture Exchange (the “TSXV”).
No data to display
EverGen Infrastructure Provides Operations and Development Updates
businesswire.com
2025-09-26 19:13:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) today provided an update on operations across its renewable natural gas (“RNG”) and organic waste processing facilities. During July and August 2025, EverGen's Fraser Valley Biogas (“FVB”) and GrowTEC facilities produced approximately 16,000 gigajoules ("GJs") (~520 GJ/d) in July and more than 17,000 GJs (~550 GJ/d) in August. These results highlight continued momentum at EverGen.
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
prnewswire.com
2025-08-28 07:00:00REHOVOT, Israel , Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer Haviv, Evogene's President and CEO, will present at the H.C.
EverGen Infrastructure Reports Q2 2025 Results
businesswire.com
2025-08-21 21:42:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), today reported financial results as at and for Q2 2025. All amounts are in Canadian dollars unless otherwise stated and have been prepared in accordance with IFRS. Strategic & Financing Updates $5 Million Private Placement: In May 2025, EverGen completed a $5 million non-brokered private placement of common shares with Ask America, LLC strengthening the Compan.
EverGen Infrastructure Announces Dates for 2025 Second Quarter Financial Results and Conference Call
businesswire.com
2025-08-19 18:28:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today announced plans to release its 2025 second quarter financial results on August 21, 2025, after market close. EverGen will hold a results and corporate update conference call at 11:00 a.m. eastern time on Friday, August 22, 2025, hosted by Chief Executive Officer, Chase Edgelow. Conference Call Details are as follows: Date: Friday, August 22, 2025 Time: 11:00.
Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-19 13:31:58Evogene Ltd. (NASDAQ:EVGN ) Q2 2025 Earnings Conference Call August 19, 2025 9:00 AM ET Company Participants Ofer Haviv - CEO, President & Director Yaron Eldad - Chief Financial Officer Unidentified Company Representative Welcome to Evogene's Second Quarter 2025 Results Conference Call.
Evogene Reports Second Quarter 2025 Financial Results
prnewswire.com
2025-08-19 07:00:00Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: The financial results for the first half of 2025 of Lavie Bio, a subsidiary of Evogene and the MicroBoost AI for Ag operations, are presented as a single-line item in Evogene's consolidated statements of profit and loss for the first half of 2025. Their results are included under the line titled - "Loss from operations held for sale, net".
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
prnewswire.com
2025-08-12 07:00:00A failure in metabolite breakdown leads to their ordered self-assembly into pathological aggregates, such as in Tyrosinemia and Gout. REHOVOT, Israel , Aug. 12, 2025 /PRNewswire/ -- Evogene Ltd.
Evogene Schedules Second Quarter 2025 Financial Results Release
prnewswire.com
2025-07-29 07:00:00Zoom conference call scheduled for August 19, 2025, 9:00 AM ET REHOVOT, Israel , July 29, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Tuesday , August 19 , 2025.
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
prnewswire.com
2025-07-08 07:00:00REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to drive innovation in life-science product development, today announced the successful completion and closing of the previously disclosed transaction involving the divestiture of the majority of the activities and assets of its ag-biologicals subsidiary, Lavie Bio Ltd.
EverGen Infrastructure Corp. Announces Appointment of Maria O'Sullivan as Interim CFO
businesswire.com
2025-06-27 02:00:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) is pleased to announce the appointment of Maria O'Sullivan as its Interim Chief Financial Officer ("CFO"), effective immediately. Ms. O'Sullivan will replace Sean Hennessy who has resigned from his role as of the same day. "On behalf of the Board of Directors and the entire team at EverGen, I would like to thank Sean for his leadership and dedication. His contributions have been.
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
prnewswire.com
2025-06-10 07:00:00The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications REHOVOT, Israel , June 10, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing life-science product discovery and development, today announced the completion of its generative AI foundation model, version 1.0, for small molecule design, developed in collaboration with Google Cloud.
EverGen Infrastructure Corp. Announces Participation in the 2025 Canadian Climate Investor Conference
newsfilecorp.com
2025-06-09 18:19:00Vancouver, British Columbia--(Newsfile Corp. - June 9, 2025) - EverGen Infrastructure Corp. (TSXV: EVGN), a Canadian renewable energy company specializing in waste-to-energy projects, announced today that it will be presenting at the 2025 Canadian Climate Investor Conference (CCIC), taking place on Wednesday June 11, 2025 at the Arcadian Court in Toronto, Ontario. For a complete agenda of the conference and to register, see the conference website here: https://events.tsx.com/ccic/.
EverGen Infrastructure Reports Q1 2025 Results
businesswire.com
2025-05-30 20:14:00VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today reported financial results as at and for Q1 2025. All amounts are in Canadian dollars unless otherwise stated and have been prepared in accordance with IFRS. Financial Highlights for Q1 2025: Revenues of $1.9 million for Q1 2025 decreased 41% compared to the same period last year, primarily driven by reduced volumes (due to unexpected operating disturbances).
Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-05-21 14:08:24Evogene Ltd. (NASDAQ:EVGN ) Q1 2025 Earnings Conference Call May 21, 2025 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Operator Welcome to Evogene's First Quarter 2025 Results Conference Call.
Evogene Reports First Quarter 2025 Financial Results
prnewswire.com
2025-05-21 07:00:00Conference call and webcast: today, May 21, 2025, 9:00 am ET Financial Highlights: In the first quarter of 2025, total revenues were approximately $2.4 million, compared to approximately $4.2 million in the first quarter of 2024. The first quarter of 2024 revenues included license fee payments totaling $3.5 million - $2.5 million from Lavie Bio's license fee under its collaboration with Corteva, and $1.0 million from AgPlenus' license fee under its collaboration with Bayer.
EverGen Infrastructure Corp. Announces Receipt of TSX Venture Exchange Final Approval of Real Property Sale and Update to Previously Announced Financing
globenewswire.com
2025-05-14 20:37:00VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) is pleased to announced that, further to its press release dated March 17, 2025, the purchase and sale agreement dated March 13, 2025 with an effective date of February 28, 2025 (the “Agreement”) between 2065947 Alberta Ltd. and James Betts (collectively, the “Purchasers”) and Fraser Valley Biogas Ltd. (the “Vendor”), a subsidiary of the Company, has received final approval from the TSX Venture Exchange (the “TSXV”).